Suchergebnisse - "Remuzzi, Giuseppe"

PubPharm (98)

1

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes : A Mediation Analysis

enthalten in: Annals of internal medicine | 2023

von Agarwal, R. | Tu, W. | Farjat, A. | +112

2

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease : A Randomized Clinical Trial (NEPHSTROM)

enthalten in: Journal of the American Society of Nephrology : JASN | 2023

von Perico, N. | Remuzzi, G. | Griffin, M. | +121

CommentIn: J Am Soc Nephrol. 2023 Dec 1;34(12):2051-2052. - PMID 38039089

3

Rationale and design of the CV-PREVITAL study : an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention

enthalten in: BMJ open | 2023

von Baldassarre, D. | Iacoviello, L. | Baetta, R. | +163

4

Effects of Octreotide-Long-Acting Release Added-on Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease : Pilot, Randomized, Placebo-Controlled, Cross-Over Trial

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2023

von Trillini, M. | Caroli, A. | Perico, N. | +14

CommentIn: Clin J Am Soc Nephrol. 2023 Feb 1;18(2):154-156. - PMID 36754002

5

Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2022

von Vart, P. | Vaduganathan, M. | Jongs, N. | +6

CommentIn: Clin J Am Soc Nephrol. 2022 Dec;17(12):1710-1712. - PMID 36414317

6

Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy : The TESTING Randomized Clinical Trial

enthalten in: JAMA | 2022

von Lv, J. | Wong, M. | Hladunewich, M. | +127

CommentIn: JAMA. 2022 May 17;327(19):1872-1874. - PMID 35579657

7

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use : An Analysis From the FIDELIO-DKD Study

enthalten in: Diabetes care | 2022

von Rossing, P. | Burgess, E. | Agarwal, R. | +113

ErratumIn: Diabetes Care. 2023 Sep 1;46(9):1721. - PMID 37310695

8

Long-term kidney and systemic effects of calorie restriction in overweight or obese type 2 diabetic patients (C.Re.S.O. 2 randomized controlled trial)

enthalten in: Diabetes research and clinical practice | 2022

von Ruggenenti, P. | Cortinovis, M. | Trillini, M. | +16

9

Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan : Final Results from Two Phase 2 Studies

enthalten in: American journal of nephrology | 2022

von Nester, C. | Appel, G. | Bomback, A. | +18

ErratumIn: Am J Nephrol. 2023 Jan 19;:1. - PMID 36657419

10

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes

enthalten in: The New England journal of medicine | 2021

von Pitt, B. | Filippatos, G. | Agarwal, R. | +109

CommentIn: Nat Rev Cardiol. 2021 Nov;18(11):738. - PMID 34508230

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]